Why the pendulum is swinging back toward independence in this specialty

Advertisement

The consolidation of private practices by hospitals, health systems and private equity groups has been sweeping across healthcare, with corporate entities now employing 82% of U.S. physicians. Steady Medicare cuts and private equity rollups have also fueled years of predictions that the independent model’s days are numbered.

But orthopedics is seeing a shift away from this trend in some markets. Fifty-four percent of orthopedic surgeons were in private practice in a 2025 American Medical Association breakdown, compared with closer to 30% of physicians in private practice in other growing 

David Jevsevar, MD, has worked inside nearly every version of orthopedic practice. Before becoming CEO of Richmond, Va.-based OrthoVirginia in 2022, he was in private practice, worked for Intermountain Healthcare and chaired orthopedics at Dartmouth-Hitchcock.

“I think that the people saying that it’s the end of independent practice is not true,” Dr. Jevsevar told Becker’s. “I can tell you that we are dealing with a large health system. There’s 150 orthopedic surgeons, and they want to get rid of all of them because they can no longer afford to have them.”

The outmigration of these physicians from the health system and into an independent network like OrthoVirginia is a trend that Dr. Jevsevar sees growing in the coming years. 

“I see the pendulum swinging back towards other models, and I think independent practice will be the preferred model,” he said. “So for that system, we may either acquire all those physicians, or we may provide services for those physicians, but that’s what I see as the big thing that nobody’s talking about.”

The cost of employing physicians continues to climb. Health systems’ median investment, or subsidy, per employed physician was $314,231 in the second quarter of 2026, according to Kaufman Hall data, and orthopedic surgeon salaries run even higher. 

“I can tell you for this health system, because I’ve done the financial analysis on it, they subsidize their orthopedic surgeons by a lot more than that,” Dr. Jevsevar said. 

Policy has added to the pressure. CMS began a three-year phaseout of the Medicare inpatient-only list in 2026, removing 285 mostly musculoskeletal procedures in the first year. The agency’s final 2027 outpatient rule, issued Nov. 4, removes 637 more services from the list.

“In orthopedics specifically, with the loss of inpatient only, that has really hurt the health systems,” Dr. Jevsevar said. “And so, at least for this health system, they have said, ‘Look, we’re good at a lot of things. We’re not good at managing specialty practices,’ and they’re not.”

OrthoVirginia is positioned to absorb that kind of volume.

“In the Virginia market, we’re by far the biggest player in the state,” Dr. Jevsevar said. “I often say that we are a small musculoskeletal health system. We have everything in our system except for hospitals.”

That size shows up in payer contracts.

“When we do transparency analysis with other folks in the state, our rates are generally 20% or 25% better than everybody else,” he said. “And I have to just be honest and say it’s because of our size.”

Smaller groups don’t have that leverage, a point Dr. Jevsevar heard directly when he presented at a recent national meeting.

“Somebody stood up and said, ‘I’m in Texas. I don’t have the ability to do what you’re doing.’ And that person was in a six-person group,” he said. “From my perspective, doing what I do, the best move you could make would be to come together with one of those groups, and I get it. People don’t want to do that. They feel that they lose autonomy, they lose control. But it’s either that, or you go the way of becoming an employee physician, or you consider the private equity route.”

Dr. Jevsevar is skeptical of the private equity route in his specialty.

“I think private equity right now in orthopedics is on a downswing, and I actually don’t see it changing. I don’t see it improving,” he said. “I think it’s going to be a hard struggle for them because there haven’t been any really successful second bites of the apple in that space.”

Each path carries its own cost.

“If you want the worst case, then join a hospital or healthcare system because you lose all autonomy, but you have stability,” Dr. Jevsevar said. “I think the problem is we’ve been used to having everything everywhere all at once. Now we’re at the point where that’s not the case anymore, right? We have to make decisions about the trade-offs. As I tell our surgeons, if we were to ever go the private equity route, we’d be selling autonomy for a price. Even if you’re part of a large independent practice like ours, there’s more autonomy than any other thing that’s out there.”

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement